The use of genomics, proteomics, and metabolomics in identifying biomarkers of male infertility

0Citations
Citations of this article
138Readers
Mendeley users who have this article in their library.

Abstract

Although male factors account for approximately 50% of all infertility, the mechanisms underlying their origin are unknown. Currently, clinicians rely primarily on semen analyses to predict male reproductive potential and chart treatment success. Even when invasive procedures are performed, the causes of male factor infertility frequently remain elusive. Recently, the advent of new technologies has spurred the search for novel male infertility biomarkers, and the detection of genes, proteins, or metabolites unique to the infertile male holds much promise. The concept that a cost-effective, noninvasive, and accurate set of biomarkers can be identified to diagnose male factor infertility is tantalizing. This review focuses on the various methodologies used in the discovery of novel biomarkers along with their findings. Specific attention is paid to recent advances in the fields of genetics, proteomics, and metabolomics. Copyright © 2013 American Society for Reproductive Medicine, Published by Elsevier Inc.

Cite

CITATION STYLE

APA

Kovac, J. R., Pastuszak, A. W., & Lamb, D. J. (2013). The use of genomics, proteomics, and metabolomics in identifying biomarkers of male infertility. In Fertility and Sterility (Vol. 99, pp. 998–1007). https://doi.org/10.1016/j.fertnstert.2013.01.111

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free